NEW YORK (GenomeWeb) – T2 Biosystems reported after the close of the market yesterday a rise in its net loss for the third quarter as costs increased amid the ongoing rollout of its Candida test.

For the three-month period ended Sept. 30, the company posted revenues in the quarter of roughly $1 million, $245,000 from product sales and $804,000 in research revenues, compared with no revenues in the third quarter of 2014. Wall Street analysts, on average, had anticipated revenues of around $700,000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.